✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Everest Organics Ltd.

EVERESTO

Market Cap
₹339 Cr.
P/E
54.67

Everest Organics Ltd.

About
Everest Organics Ltd was incorporated on 19.02.1993 to carry on the business of manufacturing of bulk drugs viz. Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Benzimadizole, etc., having its factor… Read more
Everest Organics Ltd was incorporated on 19.02.1993 to carry on the business of manufacturing … Read more
Low
113
52W Range
High
477
  • Everest Organics
  • Nectar Lifesciences
  • SMS Lifesciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Raw Material Break-Up

Operational Metrics

    locked
    Select a Metric
    • Manufacturing Capacity - Esomeprazole (MTPA)
      Source
    • Capacity Utilization - Esomeprazole (%)
      Source
    • Capacity Utilization - Benzimidazole (%)
      Source
    • Capacity Utilization - Omeprazole (%)
      Source
    • Realization - Pantaprazole Sodium (Rs/Tonne)
      Source
    • Realization - Ammonium Sulphate (Rs/Tonne)
      Source
    • Realization - Esomeprazole Magnesium (Rs/Tonne)
      Source
    • Realization - Chloro Compound (Rs/Tonne)
      Source
    • Manufacturing Capacity - Pantaprazole (MTPA)
      Source
    • Realization - Omeprazole Powder (Rs/Tonne)
      Source
    • Manufacturing Capacity - Benzimidazole (MTPA)
      Source
    • Capacity Utilization - Chloro Compound (%)
      Source
    • Realization - Benzimidazole (Rs/Tonne)
      Source
    • Realization - Op. Sulphide (Rs/Tonne)
      Source
    • Capacity Utilization - Pantaprazole (%)
      Source
    • Manufacturing Capacity - Chloro Compound (MTPA)
      Source
    • Realization - Tetralone (Rs/Tonne)
      Source
    • Manufacturing Capacity - Omeprazole (MTPA)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Everest Organics Ltd. Business

    Everest Organics Ltd was established in 1993 to manufacture bulk drugs such as Omeprazole and Ciprofloxacin. Production began in 1996 in Hyderabad.

    Everest Organics major competitors are Nectar Lifesciences, SMS Lifesciences, Bal Pharma, Smruthi Organics, Tyche Inds, Mangalam Drugs&Org., Lasa Supergenerics.
    Market Cap of Everest Organics is ₹339 Crs.
    While the median market cap of its peers are ₹138 Crs.

    Everest Organics seems to be less financially stable compared to its competitors.
    Altman Z score of Everest Organics is 2.24 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Mar Jun Sep Dec Mar Jun Sep Dec Sep Dec Mar Jun
    Investor Presentation Mar
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Everest Organics Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material